Awareness of and willingness to use pre-exposure prophylaxis (PrEP) among people who inject drugs and men who have sex with men in India: Results from a multi-city crosssectional survey

被引:25
作者
Belludi, Ashwin [1 ]
McFall, Allison M. [1 ]
Solomon, Sunil Suhas [1 ,2 ,3 ]
Celentano, David D. [1 ,2 ]
Mehta, Shruti H. [1 ]
Srikrishnan, A. K. [3 ]
Kumar, M. Suresh [3 ]
Solomon, Suniti [3 ]
Lucas, Gregory M. [2 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA
[3] YR Gaitonde Ctr AIDS Res & Educ, Chennai, Tamil Nadu, India
关键词
D O I
10.1371/journal.pone.0247352
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Introduction Pre-exposure prophylaxis (PrEP) is effective in reducing HIV transmission among key populations. In India, where PrEP is not currently part of the national HIV program, little is known about PrEP awareness, willingness to use PrEP, and barriers to uptake among people who inject drugs (PWID) and men who have sex with men (MSM). Methods We used respondent-driven sampling to accrue PWID and MSM in 22 sites from August 2016 to May 2017. Participants were asked about awareness of PrEP, willingness to use PrEP (following a brief description) and reasons why they might not be willing to use PrEP. Participants were also queried on preferences for PrEP delivery modality (oral vs. injectable). Multi-level logistic regression models were used to determine participant correlates of willingness to use PrEP. Estimates were weighted for the sampling method. Results A total of 10,538 PWID and 8,621 MSM who self-reported being HIV-negative were included in the analysis. Only 6.1% (95% confidence interval [CI]: 5.9, 6.3) of PWID and 8.0% of MSM (95% CI: 7.7, 8.4) were aware of PrEP. However, willingness to use PrEP was substantially higher in both groups: 52.4% of PWID and 67.6% of MSM. Participants commonly cited a perceived low risk for acquiring HIV infection, being perceived by others as being HIV-positive, and side effects as reasons why they would be unwilling to use PrEP. Among PWID, sharing needles and hazardous alcohol use were associated with increased willingness to use PrEP. Among MSM, having a main male partner and injection drug use were associated with increased willingness to use PrEP. Preference for daily oral or monthly injectable PrEP was similar among MSM (39.6%% vs. 41.7%,), while PWID were more likely to prefer oral to injectable administration routes (56.3% vs. 31.1%). Conclusions As India plans to roll-out of PrEP in the public sector, our multi-city survey of PWID and MSM highlights the need for key population-focused education campaigns about PrEP and self-assessment of risk.
引用
收藏
页数:17
相关论文
共 34 条
[1]  
[Anonymous], 2020, LONG ACTING INJECTAB
[2]   Humanizing an Invisible Population in India: Voices from Bisexual Men Concerning Identity, Life Experiences, and Sexual Health [J].
Banik, Swagata ;
Dodge, Brian ;
Schmidt-Sane, Megan ;
Sivasubramanian, Murugesan ;
Bowling, Jessamyn ;
Rawat, Shruta Mengle ;
Dange, Alpana ;
Anand, Vivek .
ARCHIVES OF SEXUAL BEHAVIOR, 2019, 48 (01) :305-316
[3]   Acceptability of HIV Pre-Exposure Prophylaxis (PrEP) and Implementation Challenges Among Men Who Have Sex with Men in India: A Qualitative Investigation [J].
Chakrapani, Venkatesan ;
Newman, Peter A. ;
Shunmugam, Murali ;
Mengle, Shruta ;
Varghese, Jarvis ;
Nelson, Ruban ;
Bharat, Shalini .
AIDS PATIENT CARE AND STDS, 2015, 29 (10) :569-577
[4]   Acceptability of oral and topical HIV chemoprophylaxis in India: implications for at-risk women and men who have sex with men [J].
Chandhiok, Nomita ;
Joshi, Smita N. ;
Gangakhedkar, Raman .
SEXUAL HEALTH, 2014, 11 (02) :171-179
[5]   Long-acting injectable cabotegravir for the prevention of HIV infection [J].
Clement, Meredith E. ;
Kofron, Ryan ;
Landovitz, Raphael J. .
CURRENT OPINION IN HIV AND AIDS, 2020, 15 (01) :19-26
[6]   Young people who inject drugs in India have high HIV incidence and behavioural risk: a cross-sectional study [J].
Ganapathi, Lakshmi ;
McFall, Allison M. ;
Srikrishnan, Aylur K. ;
Kumar, Muniratnam S. ;
Anand, Santhanam ;
Lucas, Gregory M. ;
Mehta, Shruti H. ;
Harris, Sion K. ;
Solomon, Sunil S. .
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2019, 22 (05)
[7]   Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men. [J].
Grant, Robert M. ;
Lama, Javier R. ;
Anderson, Peter L. ;
McMahan, Vanessa ;
Liu, Albert Y. ;
Vargas, Lorena ;
Goicochea, Pedro ;
Casapia, Martin ;
Guanira-Carranza, Juan Vicente ;
Ramirez-Cardich, Maria E. ;
Montoya-Herrera, Orlando ;
Fernandez, Telmo ;
Veloso, Valdilea G. ;
Buchbinder, Susan P. ;
Chariyalertsak, Suwat ;
Schechter, Mauro ;
Bekker, Linda-Gail ;
Mayer, Kenneth H. ;
Kallas, Esper Georges ;
Amico, K. Rivet ;
Mulligan, Kathleen ;
Bushman, Lane R. ;
Hance, Robert J. ;
Ganoza, Carmela ;
Defechereux, Patricia ;
Postle, Brian ;
Wang, Furong ;
McConnell, J. Jeff ;
Zheng, Jia-Hua ;
Lee, Jeanny ;
Rooney, James F. ;
Jaffe, Howard S. ;
Martinez, Ana I. ;
Burns, David N. ;
Glidden, David V. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (27) :2587-2599
[8]   Respondent-driven sampling II: Deriving valid population estimates from chain-referral samples of hidden populations [J].
Heckathorn, DD .
SOCIAL PROBLEMS, 2002, 49 (01) :11-34
[9]  
HIV NACOI-NIoMS, 2018, HIV NACOI NIOMS ESTI
[10]   Going global: the adoption of the World Health Organization's enabling recommendation on oral pre-exposure prophylaxis for HIV [J].
Hodges-Mameletzis, Ioannis ;
Dalal, Shona ;
Msimanga-Radebe, Busisiwe ;
Rodolph, Michelle ;
Baggaley, Rachel .
SEXUAL HEALTH, 2018, 15 (06) :489-500